Trio Health, a US-based clinical data solution provider, announced on Thursday that it has named Mia Nease as its new chief commercial officer (CCO).
In the new role, Nease is to head the advancement of the company's commercialisation strategy and manage the development of innovative solutions to meet the evolving requirements of the company's life sciences customers and collaborators.
Nease has over 25 years of experience commercialising scientific innovation. She launched a division of Dell Computer in Asia Pacific, initiating a Life Science software strategy for Hewlett Packard, and helping PwC accelerate advisory consulting revenue in the healthcare and life sciences sectors. She has held the position of vice president of partnerships for Komodo Health. She has worked on advisory boards of three health-tech startups seeking revenue growth and strategic partnerships. She will continue to serve on the board of Bryleos.
enGene names new chief financial officer and head of Business Development
The American Board of Medical Specialties names new members of the board of directors
MedGenome names new Advisory Board chairman
MentalHealth.com names new Dr Jesse Hanson as new clinical director
Element Biosciences names new director
BD names new executive vice president and chief medical officer
Fuse Oncology names new chief technology officer
Halia Therapeutics names new vice president Regulatory Affairs and new senior medical director
Rivus Pharmaceuticals names new chief medical officer
K36 Therapeutics names new chief medical officer
Kyverna Therapeutics' fifth KYV-101 Investigational New Drug application receives US FDA approval
Nereid Therapeutics names new president and chief executive officer